Julia Y Mescheriakova
Overview
Explore the profile of Julia Y Mescheriakova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
139
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mescheriakova J, van Nierop G, van der Eijk A, Kreft K, Hintzen R
Neurol Neuroimmunol Neuroinflamm
. 2020 Aug;
7(6).
PMID: 32796079
Objective: In multiplex MS families, we determined the humoral immune response to Epstein-Barr virus nuclear antigen 1 (EBNA-1)-specific immunoglobulin γ (IgG) titers in patients with MS, their healthy siblings, and...
2.
van der Vuurst de Vries R, Mescheriakova J, Wong Y, Runia T, Jafari N, Samijn J, et al.
JAMA Neurol
. 2018 Aug;
75(11):1392-1398.
PMID: 30083703
Importance: In 2017, the International Panel on Diagnosis of Multiple Sclerosis revised the McDonald 2010 criteria for the diagnosis of multiple sclerosis (MS). The new criteria are easier to apply...
3.
Mescheriakova J, Verkerk A, Amin N, Uitterlinden A, Van Duijn C, Hintzen R
Mult Scler
. 2018 Jun;
25(7):909-917.
PMID: 29873607
Background: Multiple sclerosis (MS) is a complex disease resulting from the joint effect of many genes. It has been speculated that rare variants might explain part of the missing heritability...
4.
van der Vuurst de Vries R, Wong Y, Mescheriakova J, van Pelt E, Runia T, Jafari N, et al.
Mult Scler
. 2018 May;
25(7):958-967.
PMID: 29774770
Background: A promising biomarker for axonal damage early in the disease course of multiple sclerosis (MS) is neurofilament light chain (NfL). It is unknown whether NfL has the same predictive...
5.
van der Vuurst de Vries R, Mescheriakova J, Runia T, Siepman T, Wokke B, Samijn J, et al.
J Neurol
. 2018 Feb;
265(5):1010-1015.
PMID: 29464378
Background: Cigarette smoking is a modifiable risk factor that influences the disease course of patients with multiple sclerosis (MS). However, in patients with a clinically isolated syndrome (CIS), there are...
6.
Mescheriakova J, Broer L, Wahedi S, Uitterlinden A, Van Duijn C, Hintzen R
Mult Scler J Exp Transl Clin
. 2017 Jun;
2:2055217316648721.
PMID: 28607725
Background: Approximately 20% of multiple sclerosis patients have a family history of multiple sclerosis. Studies of multiple sclerosis aggregation in families are inconclusive. Objective: To investigate the genetic burden based...
7.
van der Vuurst de Vries R, van den Dorpel J, Mescheriakova J, Runia T, Jafari N, Siepman T, et al.
Mult Scler
. 2017 May;
24(7):974-981.
PMID: 28532229
Background: Fatigue is reported by more than 75% of multiple sclerosis (MS) patients. In an earlier study, we showed that fatigue is not only a common symptom in patients at...
8.
Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome
van der Vuurst de Vries R, Mescheriakova J, Runia T, Jafari N, Siepman T, Hintzen R
JAMA Neurol
. 2017 Jan;
74(3):286-292.
PMID: 28055081
Importance: There is a growing number of therapies that could be administered after the first symptom of central nervous system demyelination. These drugs can delay multiple sclerosis (MS) diagnosis and...
9.
Lill C, Luessi F, Alcina A, Sokolova E, Ugidos N, de la Hera B, et al.
J Med Genet
. 2015 Oct;
52(12):848-55.
PMID: 26475045
Objective: A recent large-scale study in multiple sclerosis (MS) using the ImmunoChip platform reported on 11 loci that showed suggestive genetic association with MS. Additional data in sufficiently sized and...
10.
van Pelt E, Mescheriakova J, Makhani N, Ketelslegers I, Neuteboom R, Kundu S, et al.
Neurology
. 2013 Nov;
81(23):1996-2001.
PMID: 24198294
Objective: To investigate whether 57 genetic risk loci recently identified in a large-scale genome-wide association study in adult patients with multiple sclerosis (MS) are also associated with a risk for...